Latest Industry Press Releases More...

Our portal’s perpetual and fresh feed of latest happenings in the Pharmaceutical Industry is presented through the Press Releases section, which help our clients to gain a good sense of the current trade environment. This information is instrumental for future strategies.

Press Releases

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from the Phase IIa clinical study of its lead product candidate, ATX-MS-1467, for the treatment of patients with multiple sclerosis. The Phase IIa, open-label, one arm study evaluated the effects of…

Press Releases

CohBar, Inc., a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that it has completed a study to evaluate the potential efficacy of its lead drug candidates, MOTS-c peptide analogs CB4209 and CB4211, in a well-established preclinical model of nonalcoholic steatohepatitis…

Press Releases

Alberty Drugs, a leading Compounding Pharmacy in Batavia, NY has announced a significant shift in focus by concentrating the efforts of their compounding and wellness programs to servicing local Veteran Affairs Centers (VA) and other Federal Agencies. With added constraints on budgets and an increased need to secure cost effective…

Press Releases

According to a new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021" published by MarketsandMarkets, The market is projected to reach USD 52.37…

Press Releases

Hutchison China MediTech Limited (“Chi-Med”)  today announces that a Phase II study of savolitinib has been initiated in locally advanced or metastatic pulmonary sarcomatoid carcinoma (“PSC”) in China. Savolitinib is a highly selective and potent oral c-Met inhibitor with global first-in-class potential. The first drug dose was administered on February…

Press Releases

Nektar Therapeutics today announced that positive Phase 1 clinical data for Nektar's lead immuno-oncology agent, NKTR-214, in patients with renal cell carcinoma (RCC) were presented at ASCO GU 2017.  NKTR-214 is an investigational immuno-stimulatory therapy designed to expand specific cancer-fighting T cells and Natural Killer (NK) cell abundance directly in…

Press Releases

Mayne  Pharma  Group  Limited is  pleased  toannounce the launch  of butalbital  acetaminophen (APAP)tablets50mg/300mgin  the  United States. Butalbital / APAPis indicated for the treatment of tension headache (migraine). Mayne  Pharma  will distribute  the  drug  on  behalf of its  partner, Mikart  Inc.which developed  the product and is also manufacturing the product. According …

Press Releases

Catalent, Inc. (Catalent) (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has completed the acquisition of Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency and conventional pharmaceutical softgels. Financial details…

Press Releases

Ionis Pharmaceuticals, Inc. announced today that it will host a live webcast on Tuesday, February 28 at 11:30 a.m. Eastern Time to discuss its 2016 financial results and report on pipeline and business progress. Interested parties may listen to the call by dialing 877-443-5662 or access the webcast at www.ionispharma.com.…

Press Releases

Clinical Utility of Genomic Testing and Functional and Genomic Abdominal Mapping in Patients ‘ Thursday 23rd February | 3.00 pm GMT Can't make the date? Still register and we will send you the recording Presented by: Elaine Lyon, Medical Director of Molecular Genetics, ARUP Laboratories and Christina Fotopoulou, Imperial College…

loader